N1-pyrazolospiroketone acetyl-coa carboxylase inhibitors.

摘要

The invention provides a compound of Formula (I)
or a pharmaceutically acceptable salt of the compound, wherein R 1 , R 2 , R 3 and R 4 are as described herein; pharmaceutical compositions thereof; and the use thereof in treating diseases, conditions or disorders modulated by the inhibition of an acetyl-CoA carboxylase enzyme(s) in an animal.